HLN
Price
$8.82
Change
+$0.10 (+1.15%)
Updated
Sep 26, 04:05 PM (EDT)
Capitalization
39.17B
34 days until earnings call
TAK
Price
$14.65
Change
-$0.31 (-2.07%)
Updated
Sep 25 closing price
Capitalization
47.5B
34 days until earnings call
Interact to see
Advertisement

HLN vs TAK

Header iconHLN vs TAK Comparison
Open Charts HLN vs TAKBanner chart's image
Haleon
Price$8.82
Change+$0.10 (+1.15%)
Volume$3.55K
Capitalization39.17B
Takeda Pharmaceutical
Price$14.65
Change-$0.31 (-2.07%)
Volume$1.88M
Capitalization47.5B
HLN vs TAK Comparison Chart in %
Loading...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLN vs. TAK commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a StrongBuy and TAK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (HLN: $8.72 vs. TAK: $14.65)
Brand notoriety: HLN and TAK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLN: 91% vs. TAK: 49%
Market capitalization -- HLN: $39.17B vs. TAK: $47.5B
HLN [@Pharmaceuticals: Generic] is valued at $39.17B. TAK’s [@Pharmaceuticals: Generic] market capitalization is $47.5B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 1 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • HLN’s FA Score: 1 green, 4 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, TAK is a better buy in the long-term than HLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 5 TA indicator(s) are bullish while TAK’s TA Score has 5 bullish TA indicator(s).

  • HLN’s TA Score: 5 bullish, 6 bearish.
  • TAK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both HLN and TAK are a bad buy in the short-term.

Price Growth

HLN (@Pharmaceuticals: Generic) experienced а -5.63% price change this week, while TAK (@Pharmaceuticals: Generic) price change was -2.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.65%. For the same industry, the average monthly price growth was +25.29%, and the average quarterly price growth was +68.13%.

Reported Earning Dates

HLN is expected to report earnings on Oct 30, 2025.

TAK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.65% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($47.5B) has a higher market cap than HLN($39.2B). TAK has higher P/E ratio than HLN: TAK (50.58) vs HLN (19.31). TAK YTD gains are higher at: 10.733 vs. HLN (-6.408).
HLNTAKHLN / TAK
Capitalization39.2B47.5B83%
EBITDAN/A1.13T-
Gain YTD-6.40810.733-60%
P/E Ratio19.3150.5838%
RevenueN/A4.48T-
Total CashN/A419B-
Total DebtN/A4.51T-
FUNDAMENTALS RATINGS
TAK: Fundamental Ratings
TAK
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLNTAK
RSI
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 3 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 3 days ago
38%
Momentum
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 3 days ago
52%
MACD
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 3 days ago
41%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 3 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 3 days ago
40%
Advances
ODDS (%)
Bullish Trend 16 days ago
56%
Bullish Trend 16 days ago
43%
Declines
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 9 days ago
45%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 5 days ago
56%
Aroon
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 3 days ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KAPR34.05-0.06
-0.18%
Innovator Russell 2000 Pwr Bffr ETF Apr
FTEC219.24-0.69
-0.31%
Fidelity MSCI Information Tech ETF
HLAL58.81-0.29
-0.49%
Wahed FTSE USA Shariah ETF
INRO31.31-0.22
-0.70%
iShares U.S. Industry Rotation Act ETF
YSPY19.83-0.21
-1.07%
GraniteShares YieldBOOST SPY ETF

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with TAK. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
-1.69%
TAK - HLN
43%
Loosely correlated
-2.07%
ZTS - HLN
38%
Loosely correlated
-0.38%
PRGO - HLN
30%
Poorly correlated
-2.95%
VTRS - HLN
29%
Poorly correlated
-2.27%
AVDL - HLN
27%
Poorly correlated
-1.67%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-2.00%
HLN - TAK
42%
Loosely correlated
-1.69%
ZTS - TAK
30%
Poorly correlated
-0.37%
RDY - TAK
24%
Poorly correlated
-2.01%
EOLS - TAK
24%
Poorly correlated
-1.64%
EVO - TAK
23%
Poorly correlated
-4.20%
More